Gleevec is known generically as imatinib mesylate. After surgery for gastric mesenchymal tumors, 3 years of medication is recommended, with careful monitoring of adverse effects and contraindications during administration.
Unless otherwise indicated, in adults after gastric mesothelioma resection, the duration of treatment with imatinib mesylate in clinical studies is recommended to be at least 36 months, but it should be noted that there is no concept of optimal duration of imatinib mesylate treatment.
If adverse reactions such as water retention, hemorrhage, pancytopenia, hepatic insufficiency, sensory abnormalities, etc. occur during the administration of the drug, it is recommended to go to the hospital in time for medical consultation.
Take the medication with food and drink more water. If the drug breaks and contacts the skin and mucous membranes, it should be rinsed promptly. It is forbidden for those who are allergic to the drug. For pregnancy, breastfeeding, people with reproductive capacity, children under 3 years of age, need to be used with caution after strict assessment.
The drug should be administered under the supervision of a clinician.